Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology.
Virax Biolabs Group stock last closed at $0.69, down 1.43% from the previous day, and has decreased 85% in one year. It has underperformed other stocks in the Biotechnology industry by 0.63 percentage points. Virax Biolabs Group stock is currently +12.56% from its 52-week low of $0.61, and -87.33% from its 52-week high of $5.45.
There are currently 1.81M VRAX shares outstanding. The market capitalization of VRAX is $1.25M. In the past 24 hours, 3036 VRAX shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy VRAX stock.
Based on our research, eToro is the best online stock brokerage. Here's why:
Get $10 towards your share purchase by signing up for an account with eToro today.
Open eToro AccountNow that you've chosen your brokerage, the next step is to fill out some personal info so you are able to invest in VRAX stock today.
Now that you have created your account on the best stock app for beginners, your next step is to transfer the money for your investment:
Check out this video walkthrough if you need help depositing funds into your investment account.
After you have chosen the best place to buy Virax Biolabs Group stock, it's important to research their stock before you buy, so you can wrap your head around the risk as well as the opportunity.
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on VRAX's stock page.
You can use many financial metrics, analyses, models, and charts to gauge VRAX's fair value.
Using relative valuations ratios:
You can do additional valuation research on VRAX's stock here.
You can dig deeper into what analysts are forecasting on the Virax Biolabs Group stock forecast page.
Last year, VRAX revenue was $79.30k. Over the past 2 year, VRAX's revenue has grown by -15.02% per year. This was slower than the Biotechnology industry average of 28.56%.
You can analyze VRAX's earnings and revenue performance here.
Over the last year, insiders at VRAX have not bought or sold any shares.
Get more info about who owns VRAX stock here.
No, Virax Biolabs Group doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two main types of orders:
Hit the Open button and eToro will execute the order.
If you want additional help investing in stocks on eToro, watch the how to video below:
Now that you own some VRAX stock, you'll want to keep up with your new shares.
Start a watchlist to track the latest developments regarding your VRAX stock.
To summarize, here are the 6 steps for buying Virax Biolabs Group stock:
If you need a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get updates on your investment in Virax Biolabs Group, get started below.